[1]
Pilarski R, Burt R, Kohlman W, Pho L, Shannon KM, Swisher E. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. Journal of the National Cancer Institute. 2013 Nov 6:105(21):1607-16. doi: 10.1093/jnci/djt277. Epub 2013 Oct 17
[PubMed PMID: 24136893]
Level 1 (high-level) evidence
[2]
Jornayvaz FR, Philippe J. Mucocutaneous papillomatous papules in Cowden's syndrome. Clinical and experimental dermatology. 2008 Mar:33(2):151-3
[PubMed PMID: 18021272]
[3]
Elston DM. What is your diagnosis? Cowden disease (multiple hamartoma syndrome). Cutis. 2006 Jul:78(1):28, 51-2
[PubMed PMID: 16903316]
[4]
Mester J, Eng C. Cowden syndrome: recognizing and managing a not-so-rare hereditary cancer syndrome. Journal of surgical oncology. 2015 Jan:111(1):125-30. doi: 10.1002/jso.23735. Epub 2014 Aug 11
[PubMed PMID: 25132236]
[5]
Tan MH, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C. Lifetime cancer risks in individuals with germline PTEN mutations. Clinical cancer research : an official journal of the American Association for Cancer Research. 2012 Jan 15:18(2):400-7. doi: 10.1158/1078-0432.CCR-11-2283. Epub
[PubMed PMID: 22252256]
[6]
Bubien V, Bonnet F, Brouste V, Hoppe S, Barouk-Simonet E, David A, Edery P, Bottani A, Layet V, Caron O, Gilbert-Dussardier B, Delnatte C, Dugast C, Fricker JP, Bonneau D, Sevenet N, Longy M, Caux F, French Cowden Disease Network. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome. Journal of medical genetics. 2013 Apr:50(4):255-63. doi: 10.1136/jmedgenet-2012-101339. Epub 2013 Jan 18
[PubMed PMID: 23335809]
[7]
Barax CN, Lebwohl M, Phelps RG. Multiple hamartoma syndrome. Journal of the American Academy of Dermatology. 1987 Aug:17(2 Pt 2):342-6
[PubMed PMID: 3624577]
[8]
Yehia L, Ni Y, Feng F, Seyfi M, Sadler T, Frazier TW, Eng C. Distinct Alterations in Tricarboxylic Acid Cycle Metabolites Associate with Cancer and Autism Phenotypes in Cowden Syndrome and Bannayan-Riley-Ruvalcaba Syndrome. American journal of human genetics. 2019 Oct 3:105(4):813-821. doi: 10.1016/j.ajhg.2019.09.004. Epub 2019 Sep 26
[PubMed PMID: 31564436]
[9]
Lynch NE, Lynch SA, McMenamin J, Webb D. Bannayan-Riley-Ruvalcaba syndrome: a cause of extreme macrocephaly and neurodevelopmental delay. Archives of disease in childhood. 2009 Jul:94(7):553-4. doi: 10.1136/adc.2008.155663. Epub 2009 Mar 25
[PubMed PMID: 19321504]
[10]
Pilarski R. Cowden syndrome: a critical review of the clinical literature. Journal of genetic counseling. 2009 Feb:18(1):13-27. doi: 10.1007/s10897-008-9187-7. Epub 2008 Oct 30
[PubMed PMID: 18972196]
[11]
Salem OS, Steck WD. Cowden's disease (multiple hamartoma and neoplasia syndrome). A case report and review of the English literature. Journal of the American Academy of Dermatology. 1983 May:8(5):686-96
[PubMed PMID: 6863628]
Level 3 (low-level) evidence
[12]
Wade TR, Kopf AW. Cowden's disease: a case report and review of the literature. The Journal of dermatologic surgery and oncology. 1978 Jun:4(6):459-64
[PubMed PMID: 350930]
Level 3 (low-level) evidence
[13]
Gammon A, Jasperson K, Champine M. Genetic basis of Cowden syndrome and its implications for clinical practice and risk management. The application of clinical genetics. 2016:9():83-92. doi: 10.2147/TACG.S41947. Epub 2016 Jul 13
[PubMed PMID: 27471403]
[14]
Al-Zaid T, Ditelberg JS, Prieto VG, Lev D, Luthra R, Davies MA, Diwan AH, Wang WL, Lazar AJ. Trichilemmomas show loss of PTEN in Cowden syndrome but only rarely in sporadic tumors. Journal of cutaneous pathology. 2012 May:39(5):493-9. doi: 10.1111/j.1600-0560.2012.01888.x. Epub 2012 Apr 5
[PubMed PMID: 22486434]
[15]
Starink TM, Hausman R. The cutaneous pathology of facial lesions in Cowden's disease. Journal of cutaneous pathology. 1984 Oct:11(5):331-7
[PubMed PMID: 6512062]
[16]
High WA, Stewart D, Essary LR, Kageyama NP, Hoang MP, Cockerell CJ. Sclerotic fibroma-like change in various neoplastic and inflammatory skin lesions: is sclerotic fibroma a distinct entity? Journal of cutaneous pathology. 2004 May:31(5):373-8
[PubMed PMID: 15059222]
[17]
Martin H, Bessis D, Bourrat E, Mazereeuw-Hautier J, Morice-Picard F, Balguerie X, Chiaverini C, Groupe de Recherche de la Société Française de Dermatologie Pédiatrique. Cutaneous lipomas and macrocephaly as early signs of PTEN hamartoma tumor syndrome. Pediatric dermatology. 2020 Sep:37(5):839-843. doi: 10.1111/pde.14265. Epub 2020 Jul 13
[PubMed PMID: 32657433]
[18]
Masmoudi A, Chermi ZM, Marrekchi S, Raida BS, Boudaya S, Mseddi M, Jalel MT, Turki H. Cowden syndrome. Journal of dermatological case reports. 2011 Mar 26:5(1):8-13. doi: 10.3315/jdcr.2011.1063. Epub
[PubMed PMID: 21886759]
[19]
Kurek KC, Howard E, Tennant LB, Upton J, Alomari AI, Burrows PE, Chalache K, Harris DJ, Trenor CC 3rd, Eng C, Fishman SJ, Mulliken JB, Perez-Atayde AR, Kozakewich HP. PTEN hamartoma of soft tissue: a distinctive lesion in PTEN syndromes. The American journal of surgical pathology. 2012 May:36(5):671-87. doi: 10.1097/PAS.0b013e31824dd86c. Epub
[PubMed PMID: 22446940]
[20]
Mentzel T, Kutzner H, Requena L, Hartmann A. [Skin tumors as marker lesions for tumor syndromes]. Der Pathologe. 2010 Oct:31(6):489-96. doi: 10.1007/s00292-010-1361-7. Epub
[PubMed PMID: 20960199]
[21]
Kieselova K, Santiago F, Henrique M, Cunha MF. Multiple sclerotic fibromas of the skin: an important clue for the diagnosis of Cowden syndrome. BMJ case reports. 2017 Aug 28:2017():. pii: bcr-2017-221695. doi: 10.1136/bcr-2017-221695. Epub 2017 Aug 28
[PubMed PMID: 28847996]
Level 3 (low-level) evidence
[22]
Tan WH, Baris HN, Burrows PE, Robson CD, Alomari AI, Mulliken JB, Fishman SJ, Irons MB. The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and management. Journal of medical genetics. 2007 Sep:44(9):594-602
[PubMed PMID: 17526801]
[23]
Mahdi H, Mester JL, Nizialek EA, Ngeow J, Michener C, Eng C. Germline PTEN, SDHB-D, and KLLN alterations in endometrial cancer patients with Cowden and Cowden-like syndromes: an international, multicenter, prospective study. Cancer. 2015 Mar 1:121(5):688-96. doi: 10.1002/cncr.29106. Epub 2014 Nov 5
[PubMed PMID: 25376524]
[24]
Schmeler KM, Daniels MS, Brandt AC, Lu KH. Endometrial cancer in an adolescent: a possible manifestation of Cowden syndrome. Obstetrics and gynecology. 2009 Aug:114(2 Pt 2):477-479. doi: 10.1097/AOG.0b013e31819dade8. Epub
[PubMed PMID: 19622968]
[25]
Baker WD, Soisson AP, Dodson MK. Endometrial cancer in a 14-year-old girl with Cowden syndrome: a case report. The journal of obstetrics and gynaecology research. 2013 Apr:39(4):876-8. doi: 10.1111/j.1447-0756.2012.02052.x. Epub 2012 Dec 21
[PubMed PMID: 23279635]
[26]
Fackenthal JD, Marsh DJ, Richardson AL, Cummings SA, Eng C, Robinson BG, Olopade OI. Male breast cancer in Cowden syndrome patients with germline PTEN mutations. Journal of medical genetics. 2001 Mar:38(3):159-64
[PubMed PMID: 11238682]
[27]
Khandpur U, Huntoon K, Smith-Cohn M, Shaw A, Elder JB. Bilateral Recurrent Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease) in Cowden Syndrome: A Case Report and Literature Review. World neurosurgery. 2019 Jul:127():319-325. doi: 10.1016/j.wneu.2019.03.131. Epub 2019 Mar 21
[PubMed PMID: 30905649]
Level 3 (low-level) evidence
[28]
Cavaillé M, Ponelle-Chachuat F, Uhrhammer N, Viala S, Gay-Bellile M, Privat M, Bidet Y, Bignon YJ. Early Onset Multiple Primary Tumors in Atypical Presentation of Cowden Syndrome Identified by Whole-Exome-Sequencing. Frontiers in genetics. 2018:9():353. doi: 10.3389/fgene.2018.00353. Epub 2018 Aug 31
[PubMed PMID: 30233642]
[29]
Roberti V, Calvieri S, Giustini S. A case of Cowden Syndrome associated with melanoma: the role of the dermatologist. Italian journal of dermatology and venereology. 2021 Dec:156(Suppl. 1 to No. 6):29-31. doi: 10.23736/S2784-8671.19.06272-2. Epub 2019 Feb 4
[PubMed PMID: 30717572]
Level 3 (low-level) evidence
[30]
Wheeland RG, McGillis ST. Cowden's disease--treatment of cutaneous lesions using carbon dioxide laser vaporization: a comparison of conventional and superpulsed techniques. The Journal of dermatologic surgery and oncology. 1989 Oct:15(10):1055-9
[PubMed PMID: 2794201]
[31]
Iacobas I, Burrows PE, Adams DM, Sutton VR, Hollier LH, Chintagumpala MM. Oral rapamycin in the treatment of patients with hamartoma syndromes and PTEN mutation. Pediatric blood & cancer. 2011 Aug:57(2):321-3. doi: 10.1002/pbc.23098. Epub 2011 Feb 25
[PubMed PMID: 21360661]
[32]
Pradella LM, Lang M, Kurelac I, Mariani E, Guerra F, Zuntini R, Tallini G, MacKay A, Reis-Filho JS, Seri M, Turchetti D, Gasparre G. Where Birt-Hogg-Dubé meets Cowden syndrome: mirrored genetic defects in two cases of syndromic oncocytic tumours. European journal of human genetics : EJHG. 2013 Oct:21(10):1169-72. doi: 10.1038/ejhg.2013.8. Epub 2013 Feb 6
[PubMed PMID: 23386036]
Level 3 (low-level) evidence